Clinical Trials Logo

Clinical Trial Summary

This study was planned to determine whether the use of virtual reality glasses during intrauterine device insertion has an effect on the anxiety level of women.


Clinical Trial Description

Intrauterine device (IUD), which is one of the effective contraceptive methods in our country, is one of the known and frequently used methods. According to TDHS 2018 data, it was reported that 35% of women used IUD at some point in time, while the rate of women who were currently protected from pregnancy with IUD was 14% (TDHS, 2018). The fact that the rate of IUD use at any time is higher than the rate of current IUD users shows that the method is abandoned for various reasons (Kutlu & Kılıçaslan, 2014). However, although it is the most well-known method and used by one in three women in a period, the low rate of IUD use may be due to reasons such as the need to go to a health institution for application and controls, the feeling of embarrassment, discomfort and fear due to lack of information about the procedure, as well as known side effects (Kartal et al., 2013; Tan et al., 2022). However, in today's practice, no attempt is made to remove or reduce the discomfort of women, especially from vaginal examinations. It is known that virtual reality glasses are used in many areas. The most frequently used of these is the health sector. It can be used for educational purposes as well as for treatment and rehabilitation purposes. It has been stated that with virtual reality applications in treatment and rehabilitation processes, patient motivation will increase and patient fear and anxiety will decrease (Holden, 2005; Riener & Harders, 2012;Öztürk & Sondaş, 2020). In the light of the literature, it was determined that virtual reality goggles were not applied to reduce women's fear, anxiety and anxiety during IUD application. In this context, this study was planned to determine whether virtual reality goggles affect the anxiety level of women during IUD application. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06179095
Study type Interventional
Source Kirklareli University
Contact Ayça SOLT KIRCA
Phone +905392684185
Email aycasolt@hotmail.com
Status Not yet recruiting
Phase N/A
Start date February 1, 2024
Completion date February 28, 2026

See also
  Status Clinical Trial Phase
Completed NCT03686085 - Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. Phase 3
Recruiting NCT05550064 - Structured Contraceptive Counseling During Pregnancy N/A
Completed NCT03383432 - Intrauterine Device Insertion: a Step for High Satisfaction N/A
Completed NCT03600064 - Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal N/A
Completed NCT05556421 - Can Uterocervical Angle Predict the Displacement of Copper Intrauterine Devices (T-Cu 380A)
Completed NCT04045548 - Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery Phase 4
Completed NCT03870711 - 10% Lidocaine Spray for Intrauterine Device Insertion Phase 4
Completed NCT02898831 - Cold Compress for Pain Associated With Intrauterine Device Insertion N/A